About Navignostics
Navignostics is a Healthcare company based in Zurich (Switzerland) founded in 2022 by Andrea Jacobs, Jana Fischer, Bernd Bodenmiller, and Stephane Chevrier. Personalized diagnostic tests for cancer tumor indications are developed. Navignostics has raised $7.65 million across 1 funding round from investors including Bruker, University of Zurich and Think.Health. Navignostics offers products and services including Diagnostics Service and Research Support. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is Navignostics AG.
Company details
Navignostics was founded in 2022 in Zurich, Switzerland, as a developer of personalized diagnostics within the biotechnology sector. Diagnostic tests are being created to support treatments for various tumor types, with a focus on novel spatial biomarker tests for patients with metastatic colorectal cancer. Operations center on advancing precision medicine approaches for oncology.
- Headquarters Zurich, Switzerland
- Founders Andrea Jacobs, Jana Fischer, Bernd Bodenmiller, Stephane Chevrier
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website navignostics.com
- Social LinkedIn
- Legal Name Navignostics Ag
- Total Equity Funding$7.65M (USD)
in 1 rounds
- Latest Funding Round$7.65M (USD), Seed
Sep 2022
- InvestorsBruker
& 3 more
Products & Services of Navignostics
Navignostics offers a comprehensive portfolio of products and services, including Diagnostics Service and Research Support.
Analyzes tumor samples for personalized therapy options
Aids in clinical trials and new drug development
Funding Insights of Navignostics
Navignostics has successfully raised a total of $7.65M through 1 strategic funding round. The most recent funding activity was a Seed round of $7.65 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.65M
- Total Rounds 1
- Last Round Seed — $7.65M
- First Round $7.65M
(Sep 2022)
- Investors Count 4
All 1 funding rounds of Navignostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $7.65M | Seed | – | University of Zurich, Bruker |
4 investors in total: 4 institutional.
Investors in Navignostics
Navignostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Bruker, University of Zurich and Think.Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech & life sciences focused VC firm investing in geographies such as Europe | think-health.de | Furstenfeldbruck, Germany | ||
University offering multiple courses and degrees across diversified streams | 1833 | uzh.ch | Zurich, Switzerland | |
Diversified research instrument systems are manufactured and supplied. | 1960 | bruker.com | United States | |
Invests in biotech startups developing innovative therapies and technologies. | 2021 | ventura-biomed.com | Germany |
Investor details for Navignostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Navignostics
4 people are tracked at Navignostics (4 in leadership).
| Name | Role | Group |
|---|---|---|
Andrea Jacobs | Co-Founder | Leadership |
Jana Fischer | Co-Founder | Leadership |
Bernd Bodenmiller | Co-Founder | Leadership |
Stephane Chevrier | Co-Founder | Leadership |
Complete people profiles for Navignostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Navignostics
2 dated milestones of Navignostics, from founding to its latest funding, stage changes and deals.
- Founded Navignostics is founded.
- Funding First funding round of $7.6M.
Web traffic of Navignostics
The website of Navignostics (navignostics.com) receives about 3.9K visits a month.
- Monthly visits3.9K
▲ 285.1% vs previous month
Websites whose visitors overlap most with Navignostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
innosuisse.guide | innosuisse.guide | 100% | #6,279,452 | – | |
| arca24.com | 88% | 50.2K | #658,629 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Navignostics
Complete news archive for Navignostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navignostics
Navignostics was founded in 2022.
Navignostics is headquartered in Zurich, Switzerland.
Navignostics is a funded company, having raised a total of $7.65M across 1 funding round to date. The company's 1st funding round was a Seed of $7.65M, raised on Sep 2022.
Navignostics was founded in 2022 in Zurich, Switzerland, as a developer of personalized diagnostics within the biotechnology sector. Diagnostic tests are being created to support treatments for various tumor types, with a focus on novel spatial biomarker tests for patients with metastatic colorectal cancer. Operations center on advancing precision medicine approaches for oncology.
Navignostics offers Diagnostics Service and Research Support.
Navignostics has 4 investors. Key investors include Bruker, University of Zurich, Think.Health, and Ventura Biomed.
Navignostics operates through Navignostics Ag.